Delivery Order SPE2DB22D3016-SPE2DB24FBAJ1
Award Date
7/8/24
Potential Completion Date
7/9/24
Potential Value
$20K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $44,580.11 and a completion date of June 27, 2025. The contract provides for the delivery of Kisqali 600 mg daily dose 63s, a prescription medication. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $41,040.34 firm fixed-price delivery order is for the medication Kisqali 400 mg daily dose 42s, a specialty pharmaceutical product. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,499.26 firm fixed-price contract is for the delivery of KISQALI 600 MG DAILY DOSE 63S, a medical product, with a completion date of December 4, 2024. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,846.54 firm fixed price delivery order is for the supply of Kisqali 600 mg daily dose medication. The contract has an ultimate completion date of June 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,605.98, is for the delivery of KISQALI 400 MG DAILY DOSE 42S, a prescription medication. The contract is a firm fixed-price arrangement with a completion date of May 15, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,526.38 firm fixed-price contract is for the supply of KISQALI 400 MG DAILY DOSE 42S, a prescription medication. The award has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $68,334.56 firm fixed-price contract is for the delivery of KISQALI 400 MG DAILY DOSE 42S, a medical product, with a completion date of December 14, 2023. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order federal contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Kisqali 600 mg daily dose medication, with a ceiling value of $93,103.45 and a period of performance through June 23, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is also the holder of a $999,999,999.00 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,071.18, is for the supply of KISQALI 600 MG DAILY DOSE 63S, a prescription medication. The contract has an ultimate completion date of December 19, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
This is a $9,923.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the supply of KISQALI 600 MG DAILY DOSE 63S pharmaceutical products. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical prescription medications to support military treatment facilities and other federal healthcare programs. The contract has an ultimate completion date of July 22, 2024. This award is part of a...